Shafique Virani - 04 Feb 2022 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role: Chief Corp. Dev. Officer
Signature: /s/ Nathan Hatfield, attorney-in-fact
Issuer symbol: RXRX
Transactions as of: 04 Feb 2022
Net transactions value: -$12,700
Form type: 4
Filing time: 08 Feb 2022, 20:11:26 UTC
Previous filing: 04 Jun 2021
Next filing: 18 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RXRX	Class A Common Stock	Award	$0	+40,225	+63%	$0.000000	103,652	04 Feb 2022	Direct	F1, F2
transaction	RXRX	Class A Common Stock	Award	$0	+2,718	+2.6%	$0.000000	106,370	04 Feb 2022	Direct	F3
transaction	RXRX	Class A Common Stock	Tax liability	$12,700	-1,114	-1%	$11.40	105,256	04 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RXRX	Stock Option (Right to Buy)	Award	$0	+80,450		$0.000000	80,450	04 Feb 2022	Class A Common Stock	80,450	$11.40	Direct	F4
transaction	RXRX	Stock Option (Right to Buy)	Award	$0	+5,436		$0.000000	5,436	04 Feb 2022	Class A Common Stock	5,436	$11.40	Direct
holding	RXRX	Stock Option (Right to Buy)						686,955	04 Feb 2022	Class A Common Stock	686,955	$2.22	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2022 and every three months thereafter.
F2	Includes 382 shares purchased pursuant to the Issuer's Employee Stock Purchase Plan on November 22, 2021.
F3	This RSU vested immediately upon the grant date.
F4	The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F5	One forty-eighth (1/48th) of the shares subject to the award shall vest one month after March 1, 2020, or the Vesting Commencement Date, and one forty-eighth (1/48th) of the shares subject to the award shall vest each month thereafter on the same day of the month as the Vesting Commencement Date.